Insider buying
~$22K8,000 sh @ $2.72
Traded Oct 22 · filed the same day
The CEO of Anixa Biosciences paid $22K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 23, 2026 · Filed Sep 25, 2026
An Anixa Biosciences director paid $132K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$131,907
Shares × reported transaction price
$100K–$500K
+4.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 11 earlier confirmed purchases
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $2.75 on Sep 23, 2026, 17% above its 52-week low and 47% below its high, after a 15% drop over the previous 30 trading days
52-week range $2.35 (Jun 10, 2026) to $5.22 (Dec 8, 2025), 14% of the way up, from 251 adjusted closes. 30 trading days earlier: $3.22 on Aug 11, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any ANIX insider since Jul 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.7% | +1.2% | +4.5% |
| 30 days | +20.8% | +0.9% | +19.9% |
Past results only. Not a forecast.
Insider buying
Traded Oct 22 · filed the same day
The CEO of Anixa Biosciences paid $22K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
3 insiders in a week, 16th time since 2006Traded Sep 30 · filed the same day
The CFO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month. It was the first purchase in 20 months.
Insider buying
3 insiders in a week, 16th time since 2006Traded Sep 24 · filed 4 days later
The CEO of Anixa Biosciences paid $19K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Lewis H jr Titterton, Director's past purchases, 90 days after disclosure: 9 buys, median +5.8 pts vs S&P 500, beat it 6 of 9 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.